news aktuell GmbH

Flu tests from R-Biopharm also detect new virus variants

Share
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Photo: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Photo: Getty Images

Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.

"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."

This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.

About R-Biopharm

R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis. 

R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.

 

Press contact:

Simone Feiler

Head of Corporate Brand Communication

https://r-biopharm.com/de/

https://r-biopharm.com/de/kontakt/presse/

https://r-biopharm.com/de/news-presse/download-galerie/

R-Biopharm AG

An der neuen Bergstraße 17

64297 Darmstadt

Phone: 0 61 51 - 81 02-538

Mobile: 0 160 - 55 273 60

Fax: 0 61 51 - 81 02-40

Email: s.feiler@r-biopharm.de

Images

Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Photo: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Photo: Getty Images
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Debtist lanserar i Sverige: Digital inkasso utökar sin närvaro i Nordeuropa10.12.2025 12:27:47 CET | Pressmeddelande

Stockholm - Debtist, ett av Europas ledande företag inom digital inkasso, expanderar till Sverige. Det Frankfurt-baserade scale-up-företaget inkluderades nyligen i Sifted Future 50 – en utmärkelse för Europas snabbast växande techföretag. Med marknadsetableringen och ett nytt kontor i Stockholm stärker Debtist sin position i Nordeuropa och bygger vidare ut sina aktiviteter i Skandinavien. Sverige som en strategisk marknad för moderna finansprocesser Sverige är en av Europas mest digitalt avancerade ekonomier. Den höga acceptansen för automatiserade lösningar och AI-baserade teknologier gör landet till en idealisk miljö för Debtists digitala inkasso. "Etableringen i Sverige är ytterligare ett viktigt steg under ett år som präglats av stark tillväxt. Marknaden är digital, innovationsvänlig och öppen för effektiva processer. Perfekta förutsättningar för vår approach," säger Matteo Benedetti, medgründare av Debtist. Ny regional ledning: Caroline Kops blir Head of Nordics Med Caroline Kops 

Valle Venia presents Sandgrain in Space LPS feat. Lara5.12.2025 10:15:00 CET | Press Release

A Cosmic Song on Self Creation, Inner Rebirth, and the Quiet Power of Becoming Sandgrain in Space also gestures toward a vision of a “silent divine world,” a realm of clarity and heightened perception that emerges when inner turbulence dissolves. The silence referenced in the song is not emptiness but equilibrium, a moment of stillness in which the self hears itself without distortion. The song invites listeners to imagine this future world, one where illumination begins internally and radiates outward, influencing consciousness on a collective scale. This dimension gives the single an emotional resonance that extends beyond its space-driven imagery, grounding it in universal human longing for clarity, renewal, and transcendence. Musically, the single blends airy ambient textures with understated melodic movements that echo the vastness of its thematic concerns. The production opens with floating tonal fragments reminiscent of drifting light particles before expanding into luminous, sl

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye